We are excited to join the Gilmartin Group in San Francisco on May 20th for a C-Suite discussion on the Life Sciences & Biopharma Outlook.
Topics to be discussed include:
- NIH grant updates: indirect cost rate and cancellations
- Tariff policy & implications throughout Life Sciences and Biopharma
- Academic medical centers and health systems: messaging, positioning and impacts
- NIH, FDA, CDC, HHS: the new org charts, division leaders, consolidated centers & More
